In patients with gMG on concomitant IVIg treatment, concomitant use can reduce serum eculizumab concentrations and requires a supplemental dose of SOLIRIS.
Source: NLP:eculizumab
Intravenous Immunoglobulin (Ivig) Interactions
3 interactions on record
In patients with gMG, concomitant use can reduce serum eculizumab concentrations and requires supplemental dosing.
Source: NLP:eculizumab-aeeb
Concomitant use can reduce serum ravulizumab concentrations and requires a supplemental dose of ULTOMIRIS.
Source: NLP:ravulizumab